β− Arrestins: structure, function, physiology, and pharmacological perspectives

J Wess, AB Oteng, O Rivera-Gonzalez… - Pharmacological …, 2023 - ASPET
The two β-arrestins, β-arrestin-1 and-2 (systematic names: arrestin-2 and-3, respectively),
are multifunctional intracellular proteins that regulate the activity of a very large number of …

[HTML][HTML] Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention

JA McCubrey, LS Steelman, FE Bertrand, NM Davis… - Leukemia, 2014 - nature.com
Abstract Glycogen synthase kinase-3 (GSK-3) is well documented to participate in a
complex array of critical cellular processes. It was initially identified in rat skeletal muscle as …

Fulfilling the promise of" biased" G protein–coupled receptor agonism

LM Luttrell, S Maudsley, LM Bohn - Molecular pharmacology, 2015 - ASPET
The fact that over 30% of current pharmaceuticals target heptahelical G protein–coupled
receptors (GPCRs) attests to their tractability as drug targets. Although GPCR drug …

Aptamers: Uptake mechanisms and intracellular applications

S Yoon, JJ Rossi - Advanced drug delivery reviews, 2018 - Elsevier
The structural flexibility and small size of aptamers enable precise recognition of cellular
elements for imaging and therapeutic applications. The process by which aptamers are …

Emerging functional divergence of β-arrestin isoforms in GPCR function

A Srivastava, B Gupta, C Gupta, AK Shukla - Trends in Endocrinology & …, 2015 - cell.com
G protein-coupled receptors (GPCRs) are tightly regulated by multifunctional protein β-
arrestins. Two isoforms of β-arrestin sharing more than 70% sequence identity and overall …

[HTML][HTML] GPCRs in cancer: protease-activated receptors, endocytic adaptors and signaling

AKS Arakaki, WA Pan, JA Trejo - International journal of molecular …, 2018 - mdpi.com
G protein-coupled receptors (GPCRs) are a large diverse family of cell surface signaling
receptors implicated in various types of cancers. Several studies indicate that GPCRs control …

Sphingosine-1-phosphate receptors control B-cell migration through signaling components associated with primary immunodeficiencies, chronic lymphocytic …

H Sic, H Kraus, J Madl, KA Flittner… - Journal of Allergy and …, 2014 - Elsevier
Background Five different G protein–coupled sphingosine-1-phosphate (S1P) receptors
(S1P1-S1P5) regulate a variety of physiologic and pathophysiologic processes, including …

[HTML][HTML] Therapeutic potential of targeting ß-arrestin

RA Bond, EY Lucero Garcia-Rojas, A Hegde… - Frontiers in …, 2019 - frontiersin.org
ß-arrestins are multifunctional proteins that modulate heptahelical 7 transmembrane
receptors, also known as G protein-coupled receptors (GPCRs), a superfamily of receptors …

[HTML][HTML] New routes in GPCR/β-arrestin-driven signaling in cancer progression and metastasis

A Bagnato, L Rosanò - Frontiers in Pharmacology, 2019 - frontiersin.org
Tumor cells acquire invasive and metastatic behavior by sensing changes in the localization
and activation of signaling pathways, which in turn determine changes in actin cytoskeleton …

[HTML][HTML] Oligonucleotide aptamer-mediated precision therapy of hematological malignancies

S Yang, H Li, L Xu, Z Deng, W Han, Y Liu… - … Therapy-Nucleic Acids, 2018 - cell.com
Precision medicine has recently emerged as a promising strategy for cancer therapy
because it not only specifically targets cancer cells but it also does not have adverse effects …